Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
360.00    0.00 (0.00%)
Bid:
350.00
Ask:
370.00
Spread: 20.00 (5.714%)
Market Cap: £392.33m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
1st Mar 20199:49 amRNSHolding in Company
11th Jan 201910:06 amRNSHolding(s) in Company
10th Jan 20193:14 pmRNSHolding(s) in Company
21st Dec 201810:12 amRNSHolding(s) in Company
26th Nov 20184:28 pmRNSHolding in Company
23rd Nov 20183:18 pmRNSAnnual General Meeting
23rd Nov 20187:00 amRNSQ1 Trading Update
14th Nov 20183:22 pmRNSHolding in Company
5th Nov 20187:00 amRNSBlock Listing Six Monthly Return
31st Oct 20189:56 amRNSHolding in Company
25th Oct 20182:28 pmRNSPosting of 2018 Annual Report and Notice of AGM
24th Oct 20184:35 pmRNSAnnual Report and Accounts 2018
2nd Oct 20184:42 pmRNSDirector/PDMR Shareholding
2nd Oct 201812:00 pmRNSPDMR Shareholding
1st Oct 20184:59 pmRNSDirectorate Update
26th Sep 20187:00 amRNSFinal Results
26th Sep 20187:00 amRNSAppointment of CEO of new Latin American division
25th Sep 201812:37 pmRNSHolding in Company
14th Aug 20187:00 amRNSCompletion of Brazilian Acquisition
31st Jul 20187:12 amRNSHolding in Company
31st Jul 20187:00 amRNSAppointment of Head of Investor Relations
23rd Jul 20187:00 amRNSHolding in Company
18th Jul 20181:26 pmRNSHolding(s) in Company
4th Jul 20189:27 amRNSHolding in Company
19th Jun 20187:00 amRNSTrading Statement
19th Jun 20187:00 amRNSGeographical Expansion into South America
15th Jun 201810:02 amRNSHolding in Company
12th Jun 20181:12 pmRNSHolding in Company
7th Jun 20181:12 pmRNSHolding(s) in Company
7th Jun 20187:00 amRNSAppointment of Chief Financial Officer
1st Jun 20185:12 pmRNSHolding(s) in Company
17th May 201812:40 pmRNSHolding(s) in Company
17th May 20187:00 amRNSNon Executive Director Retirement
14th May 20182:58 pmRNSHolding(s) in Company
14th May 20189:16 amRNSHolding(s) in Company
4th May 20187:00 amRNSBlock Listing Six Monthly Return
16th Apr 20189:16 amRNSHolding(s) in Company
11th Apr 20185:16 pmRNSHolding(s) in Company
28th Mar 201810:54 amRNSHolding(s) in Company
28th Mar 201810:38 amRNSHolding(s) in Company
23rd Mar 201810:00 amRNSHolding(s) in Company
8th Mar 20187:02 amRNSOrganisational Announcement
8th Mar 20187:00 amRNSInterim Results
6th Mar 20185:38 pmRNSHolding(s) in Company
15th Feb 20185:20 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSDirectorate Change
31st Jan 20183:55 pmRNSHolding in Company
23rd Jan 20187:00 amRNSAcquisition
18th Jan 201811:56 amRNSHolding in Company
12th Jan 201811:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.